Tubeimoside I Sensitizes Cisplatin in Cisplatin-Resistant Human Ovarian Cancer Cells (A2780/Ddp) Through Down-Regulation of ERK and Up-Regulation of P38 Signaling Pathways

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2011.513
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy